Seroconversion and indolent course of COVID-19 in patients with multiple sclerosis treated with fingolimod and teriflunomide

Detalles Bibliográficos
Autores principales: Bollo, Luca, Guerra, Tommaso, Bavaro, Davide Fiore, Monno, Laura, Saracino, Annalisa, Angarano, Gioacchino, Paolicelli, Damiano, Trojano, Maria, Iaffaldano, Pietro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339938/
https://www.ncbi.nlm.nih.gov/pubmed/32650143
http://dx.doi.org/10.1016/j.jns.2020.117011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339938/
https://www.ncbi.nlm.nih.gov/pubmed/32650143
http://dx.doi.org/10.1016/j.jns.2020.117011

Ejemplares similares